168 related articles for article (PubMed ID: 12165492)
21. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
[TBL] [Abstract][Full Text] [Related]
22. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
[TBL] [Abstract][Full Text] [Related]
23. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
Williams NS; Kubota A; Bennett M; Kumar V; Takei F
Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
[TBL] [Abstract][Full Text] [Related]
24. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.
Roth C; Carlyle JR; Takizawa H; Raulet DH
Immunity; 2000 Jul; 13(1):143-53. PubMed ID: 10933402
[TBL] [Abstract][Full Text] [Related]
25. Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors.
Ortaldo JR; Young HA
J Immunol; 2003 Feb; 170(4):1763-9. PubMed ID: 12574340
[TBL] [Abstract][Full Text] [Related]
26. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
Hanke T; Raulet DH
J Immunol; 2001 Mar; 166(5):3002-7. PubMed ID: 11207249
[TBL] [Abstract][Full Text] [Related]
27. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
[TBL] [Abstract][Full Text] [Related]
28. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith KM; Wu J; Bakker AB; Phillips JH; Lanier LL
J Immunol; 1998 Jul; 161(1):7-10. PubMed ID: 9647200
[TBL] [Abstract][Full Text] [Related]
29. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
31. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
Held W; Kunz B
Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
[TBL] [Abstract][Full Text] [Related]
32. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.
Raziuddin A; Longo DL; Bennett M; Winkler-Pickett R; Ortaldo JR; Murphy WJ
Blood; 2002 Oct; 100(8):3026-33. PubMed ID: 12351417
[TBL] [Abstract][Full Text] [Related]
33. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
Michaëlsson J; Achour A; Rölle A; Kärre K
J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
[TBL] [Abstract][Full Text] [Related]
34. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
[TBL] [Abstract][Full Text] [Related]
35. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
36. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
[TBL] [Abstract][Full Text] [Related]
37. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.
Wu J; Cherwinski H; Spies T; Phillips JH; Lanier LL
J Exp Med; 2000 Oct; 192(7):1059-68. PubMed ID: 11015446
[TBL] [Abstract][Full Text] [Related]
38. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
Kim S; Yokoyama WM
Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
[TBL] [Abstract][Full Text] [Related]
39. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.
Mason LH; Willette-Brown J; Mason AT; McVicar D; Ortaldo JR
J Immunol; 2000 Jan; 164(2):603-11. PubMed ID: 10623801
[TBL] [Abstract][Full Text] [Related]
40. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
